Function and Regulation of Heterotrimeric G Proteins during Chemotaxis by Kamp, Marjon E et al.
  
 University of Groningen
Function and Regulation of Heterotrimeric G Proteins during Chemotaxis
Kamp, Marjon E; Liu, Youtao; Kortholt, Arjan
Published in:
International Journal of Molecular Sciences
DOI:
10.3390/ijms17010090
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2016
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Kamp, M. E., Liu, Y., & Kortholt, A. (2016). Function and Regulation of Heterotrimeric G Proteins during
Chemotaxis. International Journal of Molecular Sciences, 17(1), [90]. https://doi.org/10.3390/ijms17010090
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
 International Journal of 
Molecular Sciences
Review
Function and Regulation of Heterotrimeric G Proteins
during Chemotaxis
Marjon E. Kamp †, Youtao Liu † and Arjan Kortholt *
Received: 28 November 2015; Accepted: 31 December 2015; Published: 14 January 2016
Academic Editor: Kathleen Van Craenenbroeck
Department of Cell Biochemistry, University of Groningen, Nijenborgh 7, 9747 AG Groningen, The Netherlands;
m.e.kamp@rug.nl (M.E.K.); youtao.liu@rug.nl (Y.L.)
* Correspondence: A.Kortholt@rug.nl; Tel.: +31-50-363-4206
† These authors contributed equally to this work.
Abstract: Chemotaxis, or directional movement towards an extracellular gradient of chemicals,
is necessary for processes as diverse as finding nutrients, the immune response, metastasis and
wound healing. Activation of G-protein coupled receptors (GPCRs) is at the very base of the
chemotactic signaling pathway. Chemotaxis starts with binding of the chemoattractant to GPCRs
at the cell-surface, which finally leads to major changes in the cytoskeleton and directional cell
movement towards the chemoattractant. Many chemotaxis pathways that are directly regulated
by Gβγ have been identified and studied extensively; however, whether Gα is just a handle that
regulates the release of Gβγ or whether Gα has its own set of distinct chemotactic effectors, is only
beginning to be understood. In this review, we will discuss the different levels of regulation in GPCR
signaling and the downstream pathways that are essential for proper chemotaxis.
Keywords: chemotaxis; G-protein coupled receptors; heterotrimeric G proteins; adaptation;
non-canonical regulators; Gα effectors
1. Introduction
Chemotaxis, the process of directed cell movement towards a chemical gradient, plays an
important role in both prokaryotes and eukaryotes. Prokaryotic chemotaxis is essential for food
scavenging, while in mammals, chemotaxis plays, for example, a role in wound healing and
embryogenesis [1]. Defects in chemotaxis are critically linked to the progression of many diseases
including cancer, asthma, atherosclerosis and other chronic inflammatory diseases [2]. Although
cells can detect chemoattractant gradients of highly diverse chemical compounds produced by many
different sources, the main signaling pathways regulating chemotaxis are highly conserved among
eukaryotes [3].
The most commonly used model systems for studying chemotaxis are the slime mold Dictyostelium
discoideum and mammalian neutrophils [4]. Although having clearly distinct physiological roles,
Dictyostelium and neutrophils have a highly similar chemotactic behavior. They display strong
chemotactic responses, their stimuli are well-defined and their chemotaxis is characterized by amoeboid
migration, creating actin-rich pseudopods at the front and retracting the back of the cell using myosin
filaments [3,5]. Chemotaxis is essential for the Dictyostelium life cycle: during the vegetative phase of
their life cycle, Dictyostelium scavenges the soil for bacteria by chemotaxing towards folic acid released
by bacteria; however, if food is scarce, Dictyostelium cells secrete cyclic AMP (cAMP), which is used as
a chemoattractant by neighboring cells to form a multicellular structure with spores that can resist
harsh conditions.
During its lifecycle, Dictyostelium, as well as neutrophils, have to cope with a wide range of
chemoattractant concentrations, e.g., during development, Dictyostelium encounters cAMP gradients
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ranging from 3 nM to 10 µM [6,7]. Activation of G-protein coupled receptors (GPCRs) is at the very base
of the signaling pathways that enable this very sensitive and broad chemotaxis response. Chemotaxis
starts with binding of the chemoattractant to GPCRs at the cell surface. The receptors transmit these
signals into the interior of the cell by activation and dissociation of the heterotrimeric G protein
complex. This subsequently results in the activation of a complex network of signaling molecules
and the coordinated remodelling of the cytoskeleton. The final outcome is cellular movement up the
chemoattractant gradient [8,9].
In this review, we highlight the crucial role of regulators of GPCR and heterotrimeric G-protein
signaling and discuss the heterotrimeric pathways regulating chemotaxis.
2. Regulation of GPCRs and Heterotrimeric G Proteins during Chemotaxis
2.1. Chemotaxis Receptors and Their Regulation
Cells are able to detect and respond to a wide variety of chemoattractants and repellents, including
peptides, lipids, and small proteins of several classes [2]. Although the structure of these compounds
is highly diverse, most of them are detected by receptors of the GPCR family. The human GPCR
family consists of nearly 800 genes divided into three main families; β2 adrenergic–like receptors,
glucagon-like receptors, and metabotropic neurotransmitter-like receptors [10]. Chemotaxis receptors
belong to the family of β2 adrenergic-like receptors. An overview of the chemotaxis receptors discussed
in this review, their respective ligands and their expression is provided in Table 1. GPCRs consist of
seven transmembrane α-helices, with an intracellular C-terminus and an extracellular N-terminus [11].
The extracellular domain regulates accessibility of the receptor, the transmembrane is the main
binding surface for the ligand and, through conformational changes, the signal is transduced to the
intracellular domain, which interacts with and activates the heterotrimeric G protein signaling cascade
(see below) [8]. To be able to detect both very low and high concentrations of chemoattractant and
migrate in a complex environment of competing chemotaxis cues, GPCR activation is highly regulated.
Table 1. Overview of chemotaxis receptors discussed in this review, their respective ligands and
expression profiles. NK cell: Natural Killer cell.
Receptor Ligand(s) Cellular Expression
CCR5 CCL2/3/4/5/13/15 T cell, NK cell, monocyte, macrophage, dendritic cell
CCR6 CCL19, β-defensin B cell, T cell, NK cell, dendritic cell
CXCR2 CCL28, CXCL1/2/5/6/7/8 T cell, NK cell, neutrophil, monocyte, dendritic cell, granulocyte
CXCR4 CXCL12 (SDF-1) B cell, T cell, NK cell neutrophil, monocyte, macrophage, dendriticcell, granulocyte, neurons
CXCR5 CXCL13 B cell, T cell
BLT1/2 LTB4 B cell, T cell, neutrophil, monocyte, macrophage, dendriticcell, granulocyte
LPA1 LPA NK cell, macrophage
PAFR PAF B cell, neutrophil, monocyte
FPR1/2 Formyl peptides T cell, neutrophil, monocyte, macrophage, dendritic cell
A1 receptor Adenosine Neutrophil, monocyte, macrophage, dendritic cell
A2A receptor Adenosine B cell, NK cell, neutrophil, monocyte, macrophage, dendritic cell
A2B receptor Adenosine B cell, NK cell, neutrophil, monocyte, macrophage, dendritic cell
A3 receptor Adenosine B cell, NK cell, neutrophil, monocyte, macrophage, dendritic cell
cAR1 cAMP Dictyostelium. Peaks at 4 h of development, then drops dramatically,early aggregation
cAR2 cAMP Dictyostelium. Peaks at 16 h of development, mound formation
cAR3 cAMP Dictyostelium. Peaks at 4 h of development, then slowly decreases,late aggregation stage
cAR4 cAMP Dictyostelium. Peaks at 20 h of development, culmination
To be identified Folic acid Dictyostelium. Vegetative cells
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2.1.1. Ligand Binding Properties and Expression
In Dictyostelium, four cAMP receptors (cAR) have been identified that are involved in chemotaxis
(Table 1). To cope with an increase in extracellular cAMP concentration during the aggregation
stage [12,13], cells express the cAR1-4 receptors sequentially and with decreasing affinities. cAR2-4
have a relatively low affinity for cAMP and are important during the multicellular stage, whereas
cAR1 has a high affinity for cAMP and is essential for signal transduction during early development
and chemotaxis. At the onset of Dictyostelium aggregation the very shallow (starting from 3 nM) cAMP
gradient is detected by the high affinity (Kd of 30 nM) cAR1 receptor. At late aggregation stages, the
cAMP concentrations increase, thereby saturating cAR1 receptors [14]. The cAR1 receptors become
phosphorylated at this stage resulting in a five-fold lower affinity [15]. Subsequently, cAR1 expression
is down-regulated, while expression of the low affinity cAR3 receptor (Kd of 100 nM), cAR2 and cAR4
(both Kd in the mM range) increases, thereby enabling the cell to respond to the higher concentrations
of cAMP [16].
Neutrophils use a highly similar mechanism to sense adenosine released by tissue cells.
Inflammation or injury of tissue cells results in a more than 100-fold increase in adenosine release [17].
The cells use a combination of low and high affinity receptors to cope with these different levels of
adenosine: where A1 and A3 show an EC50 between 0.2–0.5 µM, A2A an EC50 between 0.6–0.9 µM, and
A2B an EC50 between 16–64 µM for adenosine (Table 1) [18]. At low concentrations, both high affinity
receptors A1 and A3 promote chemotaxis, while, at higher concentrations, the low affinity A2 receptors
are activated and neutrophil recruitment is diminished [17].
2.1.2. Receptor Adaptation and Internalization
Upon ligand binding, all GPCRs transiently induce their own phosphorylation (homologous
desensitization) while, as exemplified below, several receptors in addition induce phosphorylation of
other receptors (heterologous desensitization) [19]. The desensitization of the GPCRs is achieved by
the uncoupling of heterotrimeric G proteins, making it impossible for the receptor to transduce the
signal via Gα or Gβγ [20], whereas, upon removal of the ligand, resensitization is accomplished by
fast recycling of the receptors and digestion of the ligand.
The first step in desensitization is activation of G protein-coupled receptor kinases (GRKs), which
subsequently phosphorylate the C-terminal domain of the receptors (Figure 1). Phosphorylated
receptors not only have a decreased affinity for heterotrimeric G proteins, but more importantly,
also bind with higher affinity to β-arrestins [21]. β-arrestin binding uncouples heterotrimeric G
proteins from the receptor and can induce receptor internalization. Internalization can result in
either recycling to the surface and resensitization, or degradation and persistent desensitization
of receptors (Figure 1, [22,23]). Homologous receptor desensitization with associated changes in
ligand affinities allows sensitivity to a broader concentration range of chemoattractant, which has
been extensively studied for CXCR4, a chemokine receptor that responds to stromal derived factor
1 (SDF-1 or CXCL12). Upon CXCR4 phosphorylation, the E3 ubiquitin ligase IAP4 is recruited and
ubiquitinates the C-terminal tail of CXCR4 (step 5 in Figure 1) [24,25]. The ubiquitin tags the receptor
for lysosomal degradation through the endosomal sorting complex required for transport (ESCRT)
pathway. The ubiquitin tag is detected by the ubiquitin binding domain (UBD) on the ESCRT proteins
and transported to lysosomes where both the receptor and ligand are degraded (steps 11–12 in
Figure 1) [26,27]. The receptor degradation reduces signaling in high concentration gradients, and
stops cells from moving when they reach the source. Although the mechanism is not completely
understood, homologous desensitization also seems to play a role in Dictyostelium, since a mutant
strain expressing a non-phosphorylatable cAR1 showed impaired chemotaxis [28].
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Figure 1. Overview of the different pathways of chemotaxis receptor adaptation and regulation. (a) 
Agonist binding; (b) Dissociation of heterotrimeric G proteins; (c) GPCR phosphorylation by GRK’s;  
(d) Reduced affinity for heterotrimeric G proteins due to phosphorylation; (e) Ubiquitination of the 
receptor, tagging it for the degradation pathway; (f) β-arrestin binds phosphorylated receptors and 
reduces receptor affinity for heterotrimeric G proteins; (g) Interaction of β-arrestin with β2 adaptin 
(AP2) and clathrin creates clathrin coated pits, essential for receptor internalization; (h) Endocytosis 
of receptors and agonists into early endosome (EE); (i) The pH in the endosomes drops, resulting in 
disassociation of the receptor and ligand; (j) Receptors are recycled to the membrane while the 
ligands are degraded in lysosomes (L); (k) In the degradation pathway, the ubiquitin tag is detected 
by the ESCRT proteins; (l) The ESCRT proteins target the receptor sequentially to the early 
endosomes, late endosomes, multivesicular bodies (MVB) and eventually to lysosomes where both 
the receptor and ligand are degraded. 
Neutrophils operate under very complex conditions of competing chemotaxis cues and 
opposing directions. Heterologous internalization allows classification of these signals, e.g., because 
of GRK-mediated receptor phosphorylation and degradation formyl peptides of bacterial or 
mitochondrial origin are dominant attractants over CXCL8 and LTB4 for neutrophil chemotaxis [29]. 
These properties are essential for neutrophil chemotaxis towards a necrotic core; they initially use 
the CXCL2 receptor (CXCR2) to migrate up an intravascular gradient of CXCL2, which they 
subsequently ignore and instead use FPR1 to migrate up a gradient of mitochondrion-derived 
formyl peptides. 
Interestingly, recent studies have shown that β-arrestins not only regulate receptor adaptation, 
but also directly bind and activate downstream chemotaxis pathways. At the leading edge, 
β-arrestins can function as scaffold proteins for cofilin, which regulates actin polymerization at the 
front of the cell [30]. Furthermore, when the chemotaxis receptor CCR5 is activated by MIP1β 
(CCL4) a scaffold is made consisting of β-arrestin 2, PI3K and some non-receptor kinases. This 
β-arrestin 2 dependent scaffold is essential for MIP1β induced chemotaxis of human macrophages 
[31]. 
2.2. Kinetics and Regulation of Heterotrimeric G Proteins during Chemotaxis 
The general paradigm of GPCR activation is that ligand binding induces a conformational 
change in intracellular receptor domains resulting in the release of GDP from the Gα subunit (Figure 2). 
The GDP is quickly replaced by GTP from the cytosol, which promotes disassociation of the three 
subunits as Gα-GTP and a Gβγ dimer, both of which can regulate a diverse set of downstream 
effectors. Due to the intrinsic Gα-associated GTPase activity, GTP is hydrolysed to GDP, and the 
inactive heterotrimeric complex is re-associated [32]. The reassembled heterotrimeric G protein 
complex can form a complex with the GPCR again. However, it is not yet clear whether 
heterotrimeric G proteins only bind to activated receptors encountered upon lateral diffusion 
Overview of the different pathways of chemotaxis receptor d ptatio and regulation.
(a) Agonist binding; (b) Dissociation of h terotrimeric G proteins; (c) GPCR phosphorylation b
fi i f t t i t i t
t i it f r t e degra ati at ; (f) - ti i
fi f t i t i ; ( ) I ter ti f - i
l l i , t i t
i ti of the rec ptor and ligand; (j) Receptors are recycl d to the membrane while the l gands
are degr de in lysosome (L); (k) In the degradation p thway, e ubiquitin tag is detecte by he
ESCRT proteins; (l) The ESCRT proteins target the receptor sequentially to the arly endosomes, late
s s, multivesicular bodies (MVB) and ev ntually to lysosomes where both th receptor and
ligand are degraded.
eutrophils operate under very complex conditions of competing chemotaxis cues and opposing
directions. Heterologous internalization allows classification of these signals, e.g., because of GRK-mediated
receptor phosphorylation and degradation formyl peptides of bacterial or mitochondrial origin are
dominant attractants over CXCL8 and LTB4 for neutrophil chemotaxis [29]. These properties are
essential for neutrophil chemotaxis towards a necrotic core; they initially use the CXCL2 receptor
(CXCR2) to migrate up an intravascular gradient of CXCL2, which they subsequently ignore and
instead use FPR1 to migrate up a gradient of mitochondrion-derived formyl peptides.
Interestingly, recent studies have shown that β-arrestins not only regulate receptor adaptation,
but also directly bind and activate downstream chemotaxis pathways. At the leading edge, β-arrestins
can function as scaffold proteins for cofilin, which regulates actin polymerization at the front of the
cell [30]. Furthermore, when the chemotaxis receptor CCR5 is activated by MIP1β (CCL4) a scaffold
is made consisting of β-arrestin 2, PI3K and some non-receptor kinases. This β-arrestin 2 dependent
scaffold is essential for MIP1β induced chemotaxis of human macrophages [31].
2.2. Kinetics and Regulation of Heterotrimeric G Proteins during Chemotaxis
The general paradigm of GPCR activation is that ligand binding induces a conformational change
in intracellular receptor domains resulting in the release of GDP from the Gα subunit (Figure 2). The
GDP is quickly repl ce by GTP from the cytos l, which promotes disassoc ation of the three subunits
as Gα-GTP and a Gβγ dimer, both of which ca regulate a diverse set o downstream effectors. Du to
the intrins c Gα-associated GTPase activity, GTP is hydrolysed to GDP, and the ina tive heterotrimeric
complex is re-associated [32]. The reassem led heterotrimeric G protein complex can form a complex
with the GPCR again. However, it i not yet clear whether heterotrimeric G proteins only bind to
activat d r cep ors n ountered upon l teral diffusion (collision coupling model) [8,33], or whether
the G protei s are able to bind to GPCRs prior to activation (pre-coupled model) [34].
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Figure 2. A schematic representation of mammalian Gα regulation. Upon binding of extracellular 
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factors (GEFs) for Gα subunits, facilitating GDP release and subsequent binding of GTP, and release 
from Gβγ dimers (A) Non-receptor GEFs can bind to Gα-GDP and extend Gα subunit activation by 
stimulating the exchange of Gα-GDP to the active GTP-bound state. Regulator of G protein signaling 
(RGS) proteins stimulate the exchange of Gα-GTP back to Gα-GDP, serving as GTPase-accelerating 
proteins (GAPs) for Gα, thereby dramatically enhancing their intrinsic rate of GTP hydrolysis;  
(B) Upon GTP hydrolysis of Gα, the heterotrimer of Gα-GDP and Gβγ can reform, restoring the 
coupled GPCR/G protein complex; (C) However, in the presence of guanine nucleotide dissociation 
inhibitors (GDIs), Gα can become trapped in a Gα·GDP/GDI complex, preventing Gβγ from 
reassociation and re-coupling to GPCRs (D). 
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extensively studied in both mammalian and Dictyostelium cells. Activation of the receptor occurs in 
the time frame of ms [35,36], with maximum dissociation of the heterotrimeric G protein complex 
within 3–6 s after uniform stimulation with chemoattractant [37]. The amount of dissociated Gα and 
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proteins [38]. The rate limiting step in the heterotrimeric G protein activation cycle is re-association 
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several minutes in Dictyostelium cells [40]. Because of the fast intracellular response upon receptor 
activation and slow re-association rate, the signaling rate of chemotaxis receptors is limited. Under 
continuous uniform stimulation, the downstream chemotaxis pathways, such as PIP3 production, 
adapt and Dictyostelium cells stop migrating, however, surprisingly, under these conditions, the 
heterotrimeric G proteins remain dissociated from the receptor. This strongly suggests that 
ligand-bound active receptors continuously activate Gα and Gβγ subunits, and that adaptation to 
the signal at least partly occurs downstream of heterotrimeric G proteins [40]. 
Based on the conventional heterotrimeric G protein cycle, the duration of downstream signaling 
is controlled by the lifetime of the Gα subunit in its GTP-bound state. In the last couple of years, 
several guanine nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs), guanine 
nucleotide dissociation inhibitor (GDIs) and regulators of Gβγ signaling have been identified that 
regulate and fine-tune the heterotrimeric G protein signaling during chemotaxis (Figure 2, [41]). 
  
Figure 2. A schematic representation of mammalian Gα regulation. Upon binding of extracellular
chemoattractant, GPCRs undergo conformational changes to act as guanine nucleotide exchange factors
(GEFs) for Gα subunits, facilitating GDP release and subsequent binding of GTP, and release from Gβγ
dimers (A) Non-receptor GEFs can bind to Gα-GDP and extend Gα subunit activation by stimulating
the exchange of Gα-GDP to the active GTP-bound state. Regulator of G protein signaling (RGS)
proteins stimulate the exchange of Gα-GTP back to Gα-GDP, serving as GTPase-accelerating proteins
(GAPs) for Gα, thereby dramatically enhancing their intrinsic rate of GTP hydrolysis; (B) Upon GTP
hydrolysis of Gα, the heterotrimer of Gα-GDP and Gβγ can reform, restoring the coupled GPCR/G
protein complex; (C) However, in the presence of guanine nucleotide dissociation inhibitors (GDIs), Gα
can become trapped in a Gα¨ GDP/GDI complex, preventing Gβγ from reassociation and re-coupling
to GPCRs (D).
The kinetics of heterotrimeric G protein dissociation in response to chemoattractant have been
extensively studied in both mammalian and Dictyostelium cells. Activation of the receptor occurs in the
time frame of ms [35,36], with maximum dissociation of the heterotrimeric G protein complex within
3–6 s after uniform stimulation with chemoattractant [37]. The amount of dissociated Gα and Gβγ at
the front and back of Dictyostelium cells corresponds to the relative amount of cAMP at the front and
back of the cell, indicating that signal amplification occurs downstream of Gα and Gβγ proteins [38].
The rate limiting step in the heterotrimeric G protein activation cycle is re-association of Gα-GDP
and Gβγ with the receptor, which can take up to 15–30 s in mammalian cells [37,39] and several
minutes in Dictyostelium cells [40]. Because of the fast intracellular response upon receptor activation
and slow re-association rate, the signaling rate of chemotaxis receptors is limited. Under continuous
uniform stimulation, the downstream chemotaxis pathways, such as PIP3 production, adapt and
Dictyostelium cells stop migrating, however, surprisingly, under these conditions, the heterotrimeric
G proteins remain dissociated from the receptor. This strongly suggests that ligand-bound active
receptors continuously activate Gα and Gβγ subunits, and that adaptation to the signal at least partly
occurs downstream of heterotrimeric G proteins [40].
Based on the conventional heterotrimeric G protein cycle, the duration of downstream signaling is
controlled by the lifetime of the Gα subunit in its GTP-bound state. In the last couple of years, several
guanine nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs), guanine nucleotide
dissociation inhibitor (GDIs) and regulators of Gβγ signaling have been identified that regulate and
fine-tune the heterotrimeric G protein signaling during chemotaxis (Figure 2, [41]).
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2.2.1. Regulation of Gα Signaling by GEFs
In the conventional model of G protein signaling, GPCRs are the GEFs for Gα proteins, stimulating
the exchange of G protein bound GDP to GTP and inducing dissociation of free Gα-GTP and
Gβγ. However, in the last decades, several non-receptor GEFs have been identified that stabilize
a nucleotide-free transition state of Gα, thereby reducing the high nucleotide affinity by many orders
and promoting nucleotide release. This subsequently facilitates binding of GTP, which is present in
excess over GDP in the cytosol of the cell. So far, several non-receptor GEFs have been identified that
play an important role in regulating Gα activation during chemotaxis (Table 2). For instance, GIV
(Gα-interacting vesicle-associated protein, also known as Girdin) has been described as a GEF for
mammalian Gαi3 [42]. Through the GEF motif located in the C-terminus, GIV binds and exchanges
Gαi3-GDP to Gαi3-GTP that is available for the activation of downstream effectors [42]. It has been
revealed that GIV is required to stimulate the Gβγ-dependent PI3K/Akt pathway via GIV/Gαi3
activation, which remodels the actin cytoskeleton and regulates cell migration during cancer cell
invasion [42–45].
Table 2. Regulation of Gα subunit signaling in chemotaxis.
Classification G Protein Selectivity Chemotactic Downstream Pathway
GEF
GIV Gαi3 PI3K/Akt pathway
Mammalian Ric-8A Gαi/o, Gαq, and Gα12 Gαq-linked ERK activation
Mammalian Ric-8B Gαs and Gαq Not defined
D. discoideum Ric8 Gα2and Gα4 Ras, small G proteins
RGS
Mammalian RGS1 Gαi Down-regulation of Gβγ
Mammalian RGS3 Gαi Blocking binding of Gα to adenylyl cyclase
Mammalian RGS4 Gαi MAPK pathways: ERK1/2 and p38MAPKs
Mammalian RGS13 Gαi and Gαq Intracellular calcium production and pERK1/2 induction
D. discoideum RCK1 Gα2 Not defined
GDI
Mammalian AGS3/LGN Gαi Binding to Gαi-GDP and mInsc
Mammalian Rap1GAP Gαz Rap1/B-Raf/ERK pathway
Resistance to Inhibitors of Cholinesterase (Ric8A and Ric8B) are regulators of heterotrimeric
G protein signaling that can act both as non-receptor GEFs and as chaperone for Gα proteins [46].
Ric-8A only interacts with GDP-bound Gα in the absence of Gβγ, resulting in release of GDP and
formation of a stable, nucleotide-free Gα¨ Ric-8A complex. GTP then binds to Gα and disrupts the
complex, releasing Ric-8A and the activated Gα protein [47]. Ric-8A is crucial for cranial neural
crest cell migration; it localizes to the plasma membrane of the leading edge, where it amplifies Gα
signaling to downstream effectors [48]. Furthermore, silencing of Ric-8A in embryonic fibroblasts
inhibited PDGF-induced cell migration and prevented the translocation of Gα13 to the cell cortex [49].
Our work has shown that Dictyostelium Ric8 also serves as a non-receptor GEF that is important for
development and chemotaxis to cAMP and folate [50]. Dictyostelium Ric8 is not important for the
initial activation of Gα but competes with Gβγ to bind free Gα-GDP, and converts it back to the
active Gα-GTP form. It thereby amplifies and extends the G protein signal. In contrast to mammalian
Ric8, there is so far no evidence that Dictyostelium Ric8 in addition has a role as a chaperone for Gα
proteins [51]. Both in mammals and in Dictyostelium, the regulation of Ric8 is still not completely
understood. However, it has been shown that, in humans, RGS14 integrates conventional Gαi1 and
Ric8A signaling, suggesting the presence of a heterotrimeric G protein regulator complex that contains
both GAP and GEF activity [52].
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2.2.2. Regulation of Gα Signaling by RGS
The heterotrimeric G protein signal is terminated by hydrolysis of Gα-bound GTP by the intrinsic
GAP activity of Gα subunits assisted by RGS proteins (Regulators of G protein Signaling) [53–55].
So far, more than 30 family members have been recognized that all contain a conserved RGS domain
of approximately 130 amino acid residues in length which interact with active Gα subunits [56]. RGS
proteins can regulate Gα signaling pathways in three ways: (i) they act as GAPs for Gα by stimulating
the low intrinsic GTPase activity [57]; (ii) they act as effector antagonists that inhibit G proteins from
binding to their effectors [58]; and (iii) they enhance the affinity of Gα subunits for Gβγ subunits after
GTP hydrolysis, thereby accelerating reformation of the inactive heterotrimeric complex [57].
Several RGS proteins have been identified that play an important role in the regulation of
chemotaxis (Table 2). The Dictyostelium RGS domain-containing protein kinase 1 (RCK1) has been
described as a negative regulator of Dictyostelium chemotaxis, however the mechanism remains to
be determined [59]. Human RGS1 and RGS3 are important for chemotaxis of germinal center B
cells towards lymphoid tissue chemokines [37,39]. Overexpression of RGS1 and RGS3 in B cells
impaired the recruitment of B cells to inflammatory sites initiated by the two chemoattractants,
lysophosphatidic acid (LPA) and platelet-activating factor (PAF). RGS1 accelerates heterotrimeric
complex formation [60], while RGS3 probably acts as an antagonist, blocking the binding of Gα to its
effector adenylyl cyclase [39]. Human RGS4 acts as GAP for Gαi which is important for the migration
of Mv1Lu cells to fibronectin [61]. The constitutive expression of RGS13, a GAP for Gαq, reduces
B cells chemotaxis to a variety of chemoattractants, including CXC chemokine ligand 12 (CXCL12),
CXCL13, and CC chemokine ligand 19 (CCL19) [62]. Reversely, the reduction of RGS13 expression
enhances chemoattractant signaling [62]. Consistently, RGS1/RGS13 double knock-out cells have
a more polarized cellular morphology and improved chemotaxis towards CXCL12 [62]. Interestingly,
Gβγ is also important in Gα signal termination by recruitment of the R7 family of RGS proteins (RGS6,
7, 9 and 11), and subsequent R7-Gβ5 dimerization which increases the GTPase activity of Gα subunits
of the Gαi family [63].
2.2.3. Regulation of Gα Signaling by GDIs
Guanine nucleotide dissociation inhibitors (GDIs) are the third class of regulators of the
heterotrimeric G protein cycle. Gα specific GDIs possess one or more highly conserved 19-amino
acid polypeptide GoLoco (“Gαi/o-Loco” interaction) motifs that specifically interact and inhibit the
nucleotide exchange of Gα proteins [64,65]. The GoLoco motif has been identified in several diverse
proteins, including mammalian RGS12 and RGS14, Purkinje cell protein-2, Rap1GAP and GPSM2/LGN
(Table 2, [65]).
Mammalian Rap1GAP possesses both a Rap1-specific GTPase-activating protein domain and
a GoLoco motif. Previously it was shown that Rap1GAP binds Gαz in its GTP-bound state [66].
Gαz-mediated recruitment of Rap1GAP attenuated the Rap1-mediated Rap1/B-Raf/ERK signal
transduction cascade, which stimulates cell migration [67].
Activator of G protein signaling 3 (AGS3) is another well characterized GDI for Gαi [68]. AGS3
together with its homolog LGN translocates to the leading edge to form a Gαi-GDP¨ AGS3/LGN
complex. This complex simultaneously binds to mInsc, which results in mInsc-mediated targeting
of the Par3-Par6-aPKC complex to pseudopods at the leading edge to regulate directionality during
neutrophil chemotaxis [69].
2.2.4. Regulation of Gβγ Signaling
In addition, signaling of Gβγ is tightly regulated by various mechanisms. Phosducin has both
been reported as an inhibitor and activator of Gβγ signaling [70]. Initial reports showed that phosducin
competes with downstream effectors and Gα for binding to free Gβγ and thereby thus down regulates
the chemotaxis response [71]. In contrast, recently phosducin-like protein 1 (PhLP1) was shown
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to enhance Gβγ signaling by acting as a cochaperone assisting in the assembly of Gβ and Gγ into
a functional Gβγ complex [72]. Consistently, Dictyostelium cells lacking phlp1 have strongly impaired
heterotrimeric G protein signaling and are unable to chemotax [73,74].
Another regulator of Gβγ is a receptor of activated C kinase 1 (RACK1), which inhibits interaction
between Gβγ and the downstream effectors PLCβ and PI3Kγ, therefore overexpression of RACK1 or
RACK1 fragments leads to decreased leukocyte chemotaxis [75]. Conversely, WD40-repeat containing
protein 26 (WDR26) might act as a positive regulator of Gβγ signaling functioning as a scaffold
that recruits and translocates Gβγ effectors, suppression of WDR26 in HL60 cells resulted in loss of
directionality and cell migration speed. Moreover, WDR26 suppression blocks RACK1 interaction
with Gβγ, indicating that RACK1 functions downstream of WDR26 [76].
2.3. Heterotrimeric G Protein Activated Chemotaxis Pathways
As described above, amplification and cell polarization during chemotaxis is established
downstream of receptor binding and heterotrimeric G protein activation. Recent studies have identified
a complex network of GPCR regulated interconnecting signaling pathways that lead to the intracellular
amplification of the extracellular chemoattractant gradient that includes the preferential activation of
monomeric G proteins at the leading edge, major changes in the cytoskeleton with actin polymerization
at the leading edge, and actin-myosin filament assembly at the rear and sides of the cell [3]. The new
actin filaments induce the formation of local pseudopodia, while the acto-myosin filaments inhibit
pseudopod formation in the rear and retract the uropod; in this way, coordinated cell movement is
achieved [9]. Many chemotaxis pathways that are directly regulated by Gβγ have been identified
(Figure 3, [77,78]); however, we are only beginning to understand whether Gα-GDP/GTP exchange
mediates downstream signaling mainly through the release of Gβγ and/or whether distinct signaling
pathways are regulated through Gα-GTP and/or Gα-GDP subunits.
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Figure 3. A schematic representation of the chemotactic signaling pathways in mammalian neutrophils.
In the presence of PIP3, Gβγ can directly activate GEFs for Rac and Cdc42, resulting in activated
Rac and Cdc42 to promote F- tin polymerization and regulate cell motility of migrating neutrophils
through the activation of WASP and SCAR/WAVE complex. During chemotaxis, several downstream
effectors of Gα subunits have been identified: ELMO1/Dock180, p115RhoGEF, mTORC2, Homer-3
and LGN/AGS3-mInsc.
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2.3.1. Gβγ Mediated Chemotaxis Pathways
Many studies have suggested that the Gβγ dimer functions as the main transducer of chemotactic
signals [79]. Deletion of the single Gβ gene in Dictyostelium completely impairs the chemotactic
response [80]. In Dictyostelium, the released Gβγ interacts with PI3K in a Ras-dependent manner [81].
The product of PI3K, PtdIns(3,4,5)P3 (PIP3), then accumulates asymmetrically at the leading edge of
chemotaxing cells and provides a binding site for a subset of PH-domain-containing proteins, including
cytosolic regulator of adenylyl cyclase (CRAC) protein and PKB/Akt (protein kinase B). CRAC acts as
a stimulator for the adenylyl cyclase (ACA), which leads to the production of cAMP that is rapidly
secreted to stimulate neighboring cells, a process that is essential for Dictyostelium development [82,83].
PKB/Akt contributes to the regulation of cell polarity and chemotaxis through the activation of
PAKa, which is required for myosin II assembly at the rear of chemotaxing cells [84]. In addition PIP3
activates Rac small G proteins through Rac specific GEFs, resulting in the regulation of Wiskott–Aldrich
syndrome protein (WASP) and the SCAR/WAVE complex [85], which stimulate the Arp2/3 complex
that is required for the production of branched filaments and pseudopod extension [86]. Moreover,
a PH domain-containing protein A (PhdA) is another PI3K interacting PH-domain-containing protein
that regulates actin polymerization and cell polarization [87].
Despite many efforts, so far, only ElmoE has been identified as direct Gβγ effector in
Dictyostelium [88]. Gβγ mediated activation of ElmoE promotes actin polymerization at the leading
edge of chemotaxing Dictyostelium cells via the association of Dock-like proteins that function as
activator for small G proteins of the Rac family [88]. In mammalian neutrophils, in the presence of
PIP3, Gβγ can directly bind and activate P-Rex1 [89] and PIXα [90], which are GEFs for Rac and
Cdc42, respectively. This results in a gradient of activated Rac and Cdc42 to activate the WASP and
SCAR/WAVE complex at the leading edge, which is important for the regulation of cell motility and
migration of neutrophils [59,63]. Additionally, Dock2, another PIP3-dependent GEF for Rac, has been
described to play a predominant role in regulating leading edge formation [91,92]. Activated Rac and
Cdc42 together with polymerized actin act as a positive feedback loop that recruits more PIP3 in the
leading edge of the cell; however the mechanism of how PIP3 is recruited still remains unclear [93].
A recent study reveals that Gβγ can directly activate phospholipase PLCβ and its effector PKC (protein
kinase C) [94]. Further work demonstrates that both PLCβ-PKC and PI3Kγ-Akt signaling pathways
can phosphorylate and deactivate Glycogen synthase kinase 3 (GSK3) that attenuates GSK3-mediated
inhibition of the cofilin phosphatase SSH2 (slingshot2) and dephosphorylation of cofilin, leading to
fMLP-induced neutrophil polarization and actin cytoskeleton remodeling [94].
2.3.2. Gα Mediated Chemotaxis Pathways
For a long time, Gα subunits were only considered as a “timer” to govern Gβγ signaling by
regulating the release and reassociation of the Gβγ dimer. However, recently the first mammalian
Gα effectors important for chemotaxis have been reported (Figure 3, [69]), including Homer3 that
we identified as a novel Gαi2-binding protein that spatially organizes actin assembly to support
polarity and motility during neutrophil chemotaxis [95]. Gαi2 also interacts with the Elmo1/Dock180
complex functioning as a RacGEF to activate Rac1 and Rac2 proteins, thereby inducing actin
polymerization and cell migration [96]. Additionally, mInsc indirectly binds Gαi2-GDP via LGN/AGS3
and helps maintain directionality in neutrophils through its downstream effector of Par3-Par6-aPKC
complex [69]. Furthermore, the Gα12-mediated mTORC2 (mammalian TORC2)-PKC signaling pathway
is critically important for LPA induced fibroblast migration [97]. Interestingly, via the Rho specific
GEF, p115RhoGEF, Gα12/13 is able to activate Rho and its effector kinase ROCK, leading to myosin II
assembly at the rear of chemotaxing cells [98,99]. Gα-mediated pathways thus seem to be important for
both the signaling at the leading edge and rear of the cell. Surprisingly, the ELMO1/Dock180 complex
interacts specifically with Gαi2-GTP [99], while LGN/AGS3 specifically interacts with Gαi2-GDP at the
leading edge of migrating neutrophils [69]. This might suggest that free Gα can activate downstream
pathways independent of their nucleotide bound state.
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3. Conclusions
Tight regulation of GPCR and heterotrimeric G protein signaling on several levels is essential
for proper chemotaxis. Receptor affinity and expression is strictly regulated, thereby increasing the
range of concentrations to which cells can respond. Recent studies have shown the importance of
non-canonical regulators for chemotaxis: RGS, GDI and GEF proteins either extend or shorten the
lifetime of Gα-GTP, thereby fine-tuning the chemotactic response. Accumulating evidence suggests
that both Gα and Gβγ have their separate downstream pathways; however, which nucleotide bound
state of Gα transduces the signals and the exact link between heterotrimeric G protein activation and
cytoskeletal rearrangements remains to be determined. It is of high interest to fully understand the
regulations and intracellular targets of chemotaxis receptors, which could help in finding new drug
targets for several diseases, including cancer, asthma and rheumatoid arthritis.
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